Drug intelligence / Profile preview

polyethylene glycol 3350 (Puremed Biotech)

Development stage
Unknown
Lead developer
Puremed Biotech
Modality
Small Molecules
Administration
Oral
01

Overview

Megalex-PEG Syrup is a veterinary pharmaceutical product developed by Pure Med Farma, primarily used as an osmotic laxative for the treatment of constipation and fecal impaction in livestock and other animals. The active ingredient, polyethylene glycol (PEG), typically in the PEG 3350 form, works by creating an osmotic gradient that draws water into the intestinal lumen. This process increases the volume and moisture content of the stool, stimulating peristalsis and easing evacuation. Unlike stimulant laxatives, PEG is not absorbed by the intestinal mucosa, making it a preferred option for managing gastrointestinal blockages in veterinary medicine without causing systemic side effects or electrolyte imbalances.

Brand names
Megalex-PEG Syrup
Other names
Megalex-PEGpolyethylene glycol
02

Targets

Bulk water in the intestinal lumen and stool matrix

Beyond the preview

Go deeper on polyethylene glycol 3350 (Puremed Biotech).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol 3350 (Puremed Biotech).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call